chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (pressure in stomach), ABDOMINAL PAIN UPPER (stomach pain), DECREASED APPETITE (did not feel like eating or drinking), ILLNESS (sick since couple of hours after the shot) and VOMITING (three up half hour ago/throw up was dark greenish) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (pressure in stomach), ABDOMINAL PAIN UPPER (stomach pain), DECREASED APPETITE (did not feel like eating or drinking), ILLNESS (sick since couple of hours after the shot), VOMITING (three up half hour ago/throw up was dark greenish) and NAUSEA (nausea). At the time of the report, ABDOMINAL DISCOMFORT (pressure in stomach), ABDOMINAL PAIN UPPER (stomach pain), DECREASED APPETITE (did not feel like eating or drinking), ILLNESS (sick since couple of hours after the shot), VOMITING (three up half hour ago/throw up was dark greenish) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.
A pharmacist reported that an infant received only diluent for Rota Shield. Proper mixing of the diluent with the vaccine pellet did not occur. No further information was available at the date of this report. The reporter indicated that 2 infants received only diluent; however they are not presently identifiable. An additional report will be generated when identifying information is provided.
states develop sx 1/13/2022- tested positive for covid on 1/14/22 binax rapid antigen test has had 2 doses of Moderna- 2nd dose listed above, no booster dose
GUILLAIN BARRE/CIDP Dec. 25, 2009 to present - still unable to walk received IVIG, plasmapheresis, cytoxin - hospitalized 12/25/09-7/14/10.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. The patients concurrent condition included psoriasis. In approximately July 2017 reported as 2 months ago, the patient was vaccinated with ZOSTAVAX (dose, frequency, route of administration and indication were not reported). Concomitant therapies included MERCK STERILE DILUENT. On an unknown date the patient experienced flare up of psoriasis that was unstable at the time of the report. The outcome of the event was unknown. Causality assessment was not reported. Additional information has been requested.
no adverse event; patient received the GARDASIL 9 three-dose series at 60 years old; This spontaneous report was received from a consumer refers to a 60 year old female patient. On 10-MAR-2021, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route and lot # not provided) (Product administered to patient of inappropriate age). On 11-MAY-2021, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route and lot # not provided) and on 13-SEP-2021, the patient received the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route and lot # not provided). The patient stated that her doctor and her insurance company both told her that hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was approved for 60-year old women, but after receiving the series her insurance company then said it was only approved up to age 45.
Severe headache, severe fever, nausea, severe burning in sinuses, pressure in head and ears, pain in kidneys, sore body and joints
Site: Pain at Injection Site-Severe, Systemic: trouble lifting arm above head due to pain-Severe, Additional Details: I saw the patient at clinic for the reaction appx 5 days after he received the vaccine at an unknown pharmacy
Months later, for a couple hours I would get an ache (similar to effects directly after getting the Covid-19 shot) where the Covid-19 vaccine was injected. Then the ache would go away for a month and then come back. No pain, just a weird ache months after the vaccination.
About 45 mins after getting the shot. I experienced a tightening of the face with hives.  It felt like the last time I got a bee sting and found out I was allergic to bees.  My neck musscles where tight but it was not enough for me to take my epi pen  I  slepped until 5-19. only awake for about 6 hours a day. When I normally sleep that much.  Then  on 5-19.  Around noon time I woke up and was able to stay awake. I was experiencing fast heart rates from time to time. Still very tired.  I was drinking about 32 ounces of water an hour.  Then on friday 5-21. The heart issues where very severe and I went to the Emergency room.  They gave me an iv bag of fluid and I felt better but still had minnor heart fast rates from time to time.  I still felt off. and had a follow up with my primary dr.  During the visit he observed high blood preasure of around 144/90.  Currently i am observation phase and purchased a blood pressure monitor. According to the over the counter blood pressure monitor .   I have been as high as 152/106  and slowly over time it has gone down to as low as 79/58. With more of an average currently holding around 122/80. The monitor has detected two irregular hearbeats with bp stat(138/82, 82bp anb 79/58, and bp 76. I will continue to monitor and report these self monitoring finding to my primary DR on 7-6. I left a message today about updates.
Acute Glomerulonephritis, Blood and protein in urine, elevated BUN in blood.
Pain in muscle at top of shoulder that did not go away and has become worse with passing weeks. Mobility is now limited.
Day after second dose had a low fever; fatigue; swollen lymph nodes in the left side of neck; left arm swelled at injection site and raised 2" diameter; painful to touch; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 24Mar2021 at 12:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included food allergy (many, not anaphylactic) and 14 years of Lyme disease; treatment successfully completed 3 years ago. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 03Mar2021 at 13:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation and on 03Mar2021after vaccination of first dose, the patient experienced sore arm for 24 hours. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 19:00, the patient experienced left arm swelled at injection site and raised 2 diameter and painful to touch. On 25Mar2021, 1 day after vaccination, the patient experienced low fever, fatigue and swollen lymph nodes in the left side of neck. The patient did not receive any treatment for the events reported. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site swelling and painful to touch was recovered on 26Mar2021 at 19:00, after the duration of 2 days. The clinical outcome of the events low fever, fatigue and swollen lymph nodes in the left side of neck was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: updated to add Vaccine Facility Information and Concomitant Therapy was ticked as None.
Abnormally high blood sugar reading after evening meal. States no change in diet, activity normal reading of 130 or less.  1-11/06- Morning reading 102 (which is his normal range).
OPEN SORES; LOOKS LIKE SHINGLES ON BOTH SIDES UNDER THE ARMPIT AT THE BACK AREA; ITCHING RASH; PALMS, HANDS, WRIST STINGS; NECK HURTS; DIDN'T SLEEP; ACHE UNDER EARS; WRIST ACHE; EXHAUSTED; WELTS; Sluggish; This spontaneous report received from a patient and concerned a  female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. The vaccination site was left arm. No concomitant medications were reported.  On MAR-2021, the patient experienced sluggish, exhausted (PT of Fatigue) and didn't sleep; however, that could have been due to being up late to get the vaccine at 3am. On unspecified date in MAR-2021, the patient checked her temperature and reported it was fine, no value provided. On 07-MAR-2021, the patient experienced welts on both sides under her armpit at the back area in the morning, around 10 am. On 07-MAR-2021, the patient experienced open sores. On 07-MAR-2021, the patient experienced looks like shingles on both sides under the armpit at the back area and developed a rash, described as itchy. The itchiness was noticed this morning around 8-9am however it was not itchy anymore. On 07-MAR-2021, the patient experienced palms, hands, wrist stings and developed wrist ache. On 07-MAR-2021, the patient reported that her neck hurts in the morning around 4 hours after getting the vaccine. On 07-MAR-2021, the patient experienced ache under ears. The action taken with COVID-19 vaccine ad26.cov2.s was not reported. The patient recovered from itching rash on 07-MAR-2021, and had not recovered from welts, open sores, looks like shingles on both sides under the armpit at the back area, palms, hands, wrist stings, wrist ache, neck hurts, exhausted, didn't sleep, ache under ears, and sluggish. This report was non-serious.
Patient was given her second dose of the Moderna vaccine 13 days early. Patient is alert and oriented x3. breathing equal and unlabored. Airway patent. No swelling to face noted. Skin is warm/dry/race appropriate. Offender denies any difficulty breathing, chest pain, rash, difficulty swallowing, palpitations/tachycardia, dizziness or weakness. Patient denies any adverse events at this time. All vital signs are within normal limits.
Patient was under dosed. Patient received Pfizer vaccine for children 5-11 years old. Patient was 13 years old at the time of vaccination.
Inflammation in the armpit on the vaccination side. About golf ball size. Appeared the morning after the shot.
Area around injection site, about 3 X 5 ", of swelling, firm, pink, not tender.
Initial information received on 04-Jan-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves female patient's arm where the shot was given is still in tremendous pain, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site. The patient developed a non-serious arm where the shot was given is still in tremendous pain (vaccination site pain) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. (Other relevant tests included No lab test.) Final diagnosis was arm where the shot was given is still in tremendous pain. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for arm where the shot was given is still in tremendous pain.
Severe facial pain; Could not chew or talk, very debilitating; Trigeminal neuralgia; Could not chew or talk, very debilitating; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Severe facial pain), MASTICATION DISORDER (Could not chew or talk, very debilitating), TRIGEMINAL NEURALGIA (Trigeminal neuralgia) and SPEECH DISORDER (Could not chew or talk, very debilitating) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B20A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Facial pain (Patient had an episode of facial pain) since January 2021.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FACIAL PAIN (Severe facial pain), MASTICATION DISORDER (Could not chew or talk, very debilitating), TRIGEMINAL NEURALGIA (Trigeminal neuralgia) and SPEECH DISORDER (Could not chew or talk, very debilitating). At the time of the report, FACIAL PAIN (Severe facial pain), MASTICATION DISORDER (Could not chew or talk, very debilitating), TRIGEMINAL NEURALGIA (Trigeminal neuralgia) and SPEECH DISORDER (Could not chew or talk, very debilitating) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
On 11/5/99, the pt developed a rash under her breasts and arms. The pt was seen by the physician on 11/10/99 and reportedly a dx of sinus infection and fungal rash were made. She was prescribed Zithromax and a topical cream. By 11/22/99, her rash extended to her hair and eyes and completely covered her trunk and back. The pustular rash was described as red and itchy, her skin looked mottled. The pt returned to see the physician and was prescribed prednisone. On 11/29/99, she once again saw the physician and unspecified blood work and urinalysis were performed. The pt stated that her rash was drying up and that she had been seen by a dermatologist. The reporter declined to grant permission for follow-up investigation.
Swollen axillary lymph nodes ipsilateral to injection site, experienced 2 days following injection, improving   Migraine with aura (visual disturbance) evening following injection, resolved without sequalae
Received Pfizer vaccines on  4/28, 5/19/21 COVID-19 positive by PCR on  1/10/22 admitted to hospital 1/10-1/13/22 for chest pain, abd pain, hypoxia in setting of COVID 19 past history of hypoplastic left heart s/p Fontan procedure, atrial flutter s/p placement of dual-chamber epicardial pacemaker 2018
Diagnosed B-Cell Acute Lymphoblastic Leukemia, Philadelphia Chromosome negative, one month after first Pfizer vaccination. Treatment has consisted of multiple bone marrow biopsies, multiple blood transfusions, chemotherapy infusions via Dual Power Port, Multiple Intrathecal chemotherapy infusions, daily chemotherapy pills. Treatment began immediately after diagnosis date of September 22, 2021 and am still undergoing treatment until the end of January 2024.
9/5/08 Zostovax administered - 10 days later itchy, vesicular rash appeared on face/chest.  Seen in urgent care clinic 10/14/08.  Rx: doxycycline desonide.
Patient is in today for dose #2 covid vaccine. Injection was given at 0938 and then about 0933 patient told me that she is dizzy feeling. I had her get on the exam table and relax. Her vitals were 141/101, P:75, O2 100% at 0945. Staff came in and did an exam. Patient was asked to please call someone to pick her, which they will be here about 10:30. Per staff, I gave (1) 25 mg benadryl, at 1000, and then 1 to take home. Vitals at 0958 were 154/99 P: 71, and O2 100%. at 1020 vitals were 151/92 P: 72 O2: 99%. Staff came back in and checked patient and reviewed vitals. Patient was told that she could leave with her mom at 1030.
HEART RUSHING; SENSATION OF BLACKING OUT; This spontaneous report received from a consumer concerned a 60 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 15-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 15-OCT-2021, the patient experienced heart rushing. On 15-OCT-2021, the patient experienced sensation of blacking out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from heart rushing, and sensation of blacking out. This report was non-serious.
Urticarial rash 48 hrs after receiving Dtap, Hib, Pcv-7, IPV.
Large Bruising  on right leg calf and left forearm.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER731) via an unspecified route of administration in the right arm on 03Apr2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, trigeminal neuralgia, bludge dish, asthma and lower back arthritis started on an unknown date. The patient previously received acetyl salicylic acid (ASPIRIN), amoxicillin (MANUFACTURER UNKNOWN), trea nuts (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN) all for an unknown indication and from an unknown date. Concomitant medications included duloxetine hydrochloride (CYMBALTA), paracetamol (TYLENOL), multi-vitamins (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN) all for an unknown indication and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the right arm on an unknown date in Apr2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation,  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 the patient experienced large bruising on right leg calf and left forearm and smaller patches on side of right leg just appeared. No trauma to either area. The patient had doctor or other healthcare professional office or clinic visit due to the adverse events. The patient received treatment for adverse event which included physical and blood work up. The clinical outcome of the event large bruising on right leg calf and left forearm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
episode began like breath holding spell but stiffened, eyes rolled up, sans tonic clonic movements with cyanosis around the mouth lasting 30-40 seconds then seemed dazed but was screaming by the time the EMTs arrived 5 minutes later
Injection site reaction; pain; erythema; skim warm; swelling. Information has been received from a licensed practical nurse concerning a 17 year old (also reported as 14 year old) white male with diabetes mellitus juvenile onset who on 07-NOV-2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine in the left deltoid (650649/0790P), intramuscularly in the left deltoid. Concomitant therapy that day included a first dose of influenza virus split virion 3v vaccine inactivated (Fluzone) (Batch #U1792AA) intramuscularly in the right deltoid. The patient experienced a local injection site reaction after receiving pneumococcal 23v polysaccharide vaccine, described as "swollen, red warmth and pain to left deltoid". The patient was told to use ice 2 to 3 times an hour and ibuprofen (Advil) and diphenhydramine hydrochloride (Benadryl). The patient recovered on 11-NOV-2005. There was no illness at the time of vaccination. The patient did not experience any adverse events following prior vaccinations. The records testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. In addition, a review of the Quality Control Quarantine/Rejection System revealed that there were no open Quarantines registered against this lot/fill. Additional information not expected.
07/18/2017 0200 Awoke with chills. Went to work that morning, continue to feel bad. Nausea, headache, chills, body aches.  330 Reported to Employee Health. T99.4 F. Chills, nausea, headache, body aches. No hives, no swelling, no shortness of breath per patient. Encourage to go home and rest, take TYLENOL. 1730 follow up phone call. Had taken TYLENOL, slept. Woke in a sweat, broke fever, reported feeling better. 7/19/2017 0830 Reported to work that morning, reports slight nausea, no aches, no fever, continues to feel better.
get really sick; Initial information received on 15-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer (Patient) via social media.   Medical history, medical treatment(s), past vaccination, family history and concomitant medication was not reported.   On an unknown date, the patient received a dose of INFLUENZA VACCINE produced by an unknown manufacturer (lot number and expiry date were not reported) via an unknown route in an unknown administration site.    On an unknown date (unknown latency), the patient got INFLUENZA VACCINE and patient got get really sick  (illness).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
this was a pediatric booster.  The stock vial was not diluted before 0.2ml was drawn out to be dosed.  As of 10/21/22 the father has indicated no side effects have been experienced.
Patient received vaccine and minutes later felt dizzy, sweaty, syncopal. VS:  BP 106/67; P 80; RR 16; Pulse Ox 100% on RA
Ovarian Cancer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing). No known allergies. Concomitant medication(s) included: LEVOTHYROXINE. Vaccination history included: Bnt162b2 (Dose Number: 1; Location of injection: Arm Left), for COVID-19 immunization.  The following information was reported: OVARIAN CANCER (hospitalization, life threatening) with onset 01Dec2021, outcome "unknown". The patient was hospitalized for ovarian cancer (hospitalization duration: 2 day(s)). Therapeutic measures were taken as a result of ovarian cancer included surgery. Clinical course: Facility type vaccine was pharmacy or drug store. No other vaccine in four weeks. Other medications in two weeks: levothyroxine. No Covid prior vaccination. No Covid tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Lightheadness, dizziness, and low pressure (91/63) within 15 minutes of the immunization
c/o nausea and vomitting 15 mins post vaccination, vomitted x 1, zofran given x 1; hashx of DM, vital signs are stable; nausea relieved by meds; observed for 30 more mins; client feeling better declined hospitalization; discharged home with son driving client home.